Ordinary shares, 0.000025 nominal value as at june30, 2026 40,848,893 shares authorized, issued and outstanding and as at december31, 2025
1
1
1
1
Deferred a shares, 1 nominal value 63,443 shares authorized, issued and outstanding (december31, 2024 authorized, issued and outstanding 63,443)-Deferred Shares.
-
-
-
86
Deferred a shares, 1 nominal value as at june30, 2026 63,443 shares authorized, issued and outstanding and as at december31, 2025
86
86
86
-
Additional paid-in capital
394,932
394,499
393,944
393,248
Accumulated deficit
-320,208
-309,628
-304,092
-293,002
Accumulated other comprehensive loss foreign currency translation adjustments
-17,738
-18,559
-15,731
-15,868
Total stockholders equity attributable to barinthus biotherapeutics plc shareholders
57,073
66,399
74,208
84,465
Noncontrolling interest
61
79
84
96
Total stockholders equity
57,134
66,478
74,292
84,561
Total liabilities and stockholders equity
81,893
92,143
98,169
109,201
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.